Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | PRNP | P04156 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7140275 | 0.97 | ALDH1A1 (0.54) | ALDH1A1HSD17B10LMNAKDM4EPRNP | |
| SCHEMBL3823636 | 0.87 | TDP1 (0.50) | ALDH1A1HSD17B10LMNAKDM4EPRNP | |
| SCHEMBL9375831 | 0.85 | ALDH1A1 (0.46) | ALDH1A1HSD17B10LMNAKDM4EPRNP | |
| SCHEMBL31210189 | 0.81 | — | — | |
| SCHEMBL26863630 | 0.81 | — | — | |
| SCHEMBL18913028 | 0.81 | LMNA (0.43) | ALDH1A1HSD17B10LMNAKDM4EPRNP | |
| SCHEMBL14999641 | 0.79 | — | — | |
| SCHEMBL7152839 | 0.79 | — | — | |
| SCHEMBL4930089 | 0.79 | — | — | |
| SCHEMBL18547147 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100280186-A1 | FURANIC-MODIFIED AMINE-BASED CURATIVES | BATTELLE MEMORIAL INSTITUTE | 2010-11-04 | — | — | US | claimed |
| US-20080207847-A1 | Furanic-modified amine-based curatives | BATTELLE MEMORIAL INSTITUTE | 2008-08-28 | — | — | US | claimed |
| US-20100280186-A1 | FURANIC-MODIFIED AMINE-BASED CURATIVES | BATTELLE MEMORIAL INSTITUTE | 2010-11-04 | — | — | US | disclosed |
| US-20080207847-A1 | Furanic-modified amine-based curatives | BATTELLE MEMORIAL INSTITUTE | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280186-A1 | FURANIC-MODIFIED AMINE-BASED CURATIVES | UMPS, SRM, PAM | ALDH1A1 705/4885HSD17B10 2754/4885LMNA 2714/4885 |
| US-20080207847-A1 | Furanic-modified amine-based curatives | DDC, AOC1, ESD | ALDH1A1 428/4885HSD17B10 1560/4885LMNA 1319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.